Abstract
E proteins function in many developmental processes and are essential for the formation of lymphocyte progenitors. However, it is not known whether E proteins regulate lymphocyte survival, proliferation or differentiation or how their activity is regulated during lymphocyte development. We show here a role for Id3, an inhibitor of E protein activity, in the induction of apoptosis and growth arrest. Id3 is induced in response to transforming growth factor β (TGF-β), a pleiotropic cytokine that inhibits the growth and survival of normal and transformed lymphocyte progenitors. In the absence of Id3, the response of lymphocyte progenitors to TGF-β is perturbed, which indicates that Id3 is a mediator of this response. Our data show a key role for E proteins in lymphocyte survival and link the activity of E proteins, and their antagonists, to members of the TGF-β family of cytokines.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Murre, C. et al. Structure and function of helix-loop-helix proteins. Biochim. Biophys. Acta 1218, 129–135 (1994).
Benezra, R., Davis, R. L., Lockshon, D., Turner, D. L. & Weintraub, H. The protein Id: a negative regulator of helix-loop-helix DNA binding proteins. Cell 61, 49–59 (1990).
Davis, R. L., Weintraub, H. & Lassar, A. B. Expression of a single transfected cDNA converts fibroblasts to myoblasts. Cell 51, 987–1000 (1987).
Lee, J. E. et al. Conversion of Xenopus ectoderm into neruons by NeuroD, a basic helix-loop-helix protein. Science 268, 836–844 (1995).
Bain, G. et al. E2A proteins are required for proper B cell development and initiation of immunoglobulin gene rearrangements. Cell 79, 885–892 (1994).
Zhuang, Y., Soriano, P. & Weintraub, H. The helix-loop-helix gene E2A is required for B cell formation. Cell 79, 875–884 (1994).
Sun, X.-H. Constitutive expression of the Id1 gene impairs mouse B cell development. Cell 79, 893–900 (1994).
Heemskerk, M. H. M. et al. Inhibition of T cell and promotion of natural killer cell development by the dominant negative helix loop helix factor Id3. J. Exp. Med. 186, 1597–1602 (1997).
Bain, G. et al. E2A deficiency leads to abnormalities in β T-cell development and to rapid development of T-cell lymphomas. Mol. Cell. Biol. 17, 4782–4791 (1997).
Yan, W. et al. High incidence of T-cell tumors in E2A-null mice and E2A/Id1 double-knockout mice. Mol. Cell. Biol. 17, 7317–7327 (1997).
Zhuang, Y., Cheng, P. & Weintraub, H. B-Lymphocyte development is regulated by the combined dosage of three basic helix-loop-helix genes, E2A, E2-2, and HEB. Mol. Cell. Biol. 16, 2898–2905 (1996).
Lee, G., Namen, A. E., Gillis, S., Ellingsworth, L. R. & Kincade, P. W. Normal B cell precursors responsive to recombinant murine IL-7 and inhibition of IL-7 activity by transforming growth factor-β. J. Immunol. 142, 3875–3883 (1989).
Chantry, D., Turner, M. & Feldmann, M. Interleukin 7 (murine pre-B cell growth factor/lymphopoietin 1) stimulates thymocyte growth: regulation by transforming growth factor β. Eur. J. Immunol. 19, 783–786 (1989).
Shull, M. M. et al. Targeted disruption of the mouse transforming growth factor-β 1 gene results in multifocal inflammatory disease. Nature 359, 693–699 (1992).
Kulkarni, A. B. et al. Transforming growth factor β 1 null mutation in mice causes excessive inflammatory response and early death. Proc. Natl Acad. Sci. USA 90, 770–774 (1993).
Yaswen, L. et al. Autoimmune manifestations in the transforming growth factor-β1 knockout mouse. Blood 87, 1439–1445 (1996).
Gorelik, L. & Flavell, R. A. Abrogation of TGFβ signaling in T cells leads to spontaneous T cell differentiation and autoimmune disease. Immunity 12, 171–181 (2000).
Cazac, B. B. & Roes, J. TGF-β receptor controls B cell responsiveness and induction of IgA in vivo. Immunity 13, 443–451 (2000).
Saltzman, A. et al. Transforming growth factor-β-mediated apoptosis in the Ramos B-Lymphom cell line is accompanied by caspase activation and Bcl-xL downregulation. Exp. Cell Res. 242, 244–254 (1998).
Buske, C. et al. TGF-β and its receptor complex in leukemic B-cell precursors. Exp. Hematol. 26, 1155–1161 (1998).
Lotz, M., Ranheim, E. & Kipps, T. J. Transforming growth factor β as endogenous growth inhibitor of chronic lymphocytic leukemia B cells. J. Exp. Med. 179, 999–1004 (1994).
Douglas, R. S., Capocasle, R. J., Lamb, R. J., Nowell, P. C. & Moore, J. S. Chronic lymphocytic leukemia B cell are resistant to the apoptotic effects of transforming growth factor-β. Blood 89, 941–947 (1997).
Pear, W. S., Nolan, G. P., Scott, M. L. & Baltimore, D. Production of high-titer helper-free retroviruses by transient transfection. Proc. Natl Acad. Sci. USA 90, 8392–8396 (1993).
Quong, M. W., Harris, D. P., Swain, S. L. & Murre, C. E2A activity is induced during B-cell activation to promote immunoglobulin class switch recombination. EMBO J. 18, 6307–6318 (1999).
Vermes, I., Haanen, C., Steffens-Nakken, H. & Reutelingsperger, C. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labeled Annexin V. J. Immunol. Meth. 184, 39–51 (1995).
Salvesen, G. S. & Dixit, V. M. Caspases:intracellular signaling by proteolysis. Cell 91, 443–446 (1997).
Whitman, M. Smads and early developmental signaling by the TGFβ superfamily. Genes Dev. 12, 2445–2462 (1998).
Arsura, M., Wu, M. & Sonenshein, G. E. TGFβ1 inhibits NF-κB/Rel activity inducing apoptosis of B cells: Transcriptional actiation of IκBα. Immunity 5, 31–40 (1996).
Schlissel, M., Voronova, A. & Baltimore, D. Helix-loop-helix transcription factor E47 activates germ-line immunoglobulin heavy-chain transcription and rearrangement in a pre-T-cell line. Genes Dev. 5, 1367–1376 (1991).
Kee, B. L. & Murre, C. Induction of early B cell factor (EBF) and multiple B lineage genes by the basic helix-loop-helix transcription factor E12. J. Exp. Med. 188, 699–713 (1998).
Lasorella, A., Noseda, M., Beyna, M. & Iavarone, A. Id2 is a retinoblastoma protein target and mediates signalling by myc oncoproteins. Nature 407, 592–598 (2000).
Massague, J. TGF-β signal transduction. Annu. Rev. Biochem. 67, 753–791 (1998).
Baker, J. C. & Harland, R. M. From receptor to nucleus: the Smad pathway. Curr. Opin. Gen. Dev. 7, 467–473 (1997).
Nakao, A. et al. Identification of Smad7, a TGF-β-inducible antagonist of TGF-β signalling. Nature 389, 631–635 (1997).
Hayashi, H. et al. The MAD-related protein Smad7 associates with the TGFβ receptor and functions as an antagonist of TGFβ signaling. Cell 89, 1165–1173 (1997).
Lo, R. S. & Massague, J. Ubiquitin-dependent degradation of TGF-β-activated Smad2. Nature Cell Biol. 1, 472–478 (1999).
Bain, G. et al. Regulation of the helix-loop-helix proteins, E2A and Id3, by the Ras-ERK MAPK cascade. Nature Immunol. 2, 165–171 (2001).
Nagahara, H. et al. Transduction of full-length TAT fusion proteins into mammalian cell: TAT-p27Kip1 induces cell migration. Nature Med. 4, 1449–1452 (1998).
Rivera, R. R., Johns, C. P., Quan, J., Johnson, R. S. & Murre, C. Thymocyte selection is regulated by the helix-loop-helix inhibitor protein, Id3. Immunity 12, 17–26 (2000).
Pan, L. Sato, S. Frederick, J P., Sun, X.-H. & Zhuang, Y. Impaired immune responses and B-cell proliferation in mice lacking the Id3 gene. Mol. Cell. Biol. 19, 5969–5980 (1999).
Miyazaki, M. et al. Transforming growth factor-β1 stimulates or inhibits cell growth via down- or up-regulation of p21/Waf1. Biochem. Biophy. Res. Comm. 246, 873–880 (1998).
Kamesaki, H., Nishizawa, K., Michaud, G. Y., Cossman, J. & Kiyono, T. TGF-β1 induces the cyclin-dependent kinase inhibitor p27Kip1 mRNA and protein in murine B cells. J. Immunol. 160, 770–777 (1998).
Wu, M., Bellas, R. E., Shen, J., Yang, W. & Sonenshein, G. E. Increased p27Kip1 cyclin-dependent kinase inhibitor gene expression following anti-IgM treatment promotes apoptosis of WEHI 231 B cells. J. Immunol. 163, 6530–6535 (1999).
Hannon, G. J. & Beach, D. p15INK4B is a potential effector of TGF-β-induced cell cycle arrest. Nature 371, 257–261 (1994).
Warner, B. J., Blain, S. W., Seoane, J. & Massague, J. Myc downregulation by transforming growth factor β required for activation of the p15Ink4b pathway. Mol. Cell. Biol. 19, 5913–5922 (1999).
Hollnagel, A., Oehlmann, V., Heymer, J., Ulrich, R. & Nordheim, A. Id genes are direct targets of bone morphogenetic protein induction in embryonic stem cells. J. Biol. Chem. 274, 19838–19845 (1999).
Heath, V. L., Murphy, E. E., Crain, C., Tomlinson, M. G. & O'Garra, A. TGF-β1 down-regulates Th2 development and results in decreased IL-4-induced STAT6 activation and GATA-3 expression. Eur. J. Immunol. 30, 2639–2649 (2000).
Gorelik, L., Fields, P. E. & Flavell, R. A. TGF-β inhibits Th type 2 development through inhibition of GATA-3 expression. J. Immunol. 165, 4773–4777 (2000).
Kee, B. L., Quong, M. W. & Murre, C. E2A proteins: Essential regulators at multiple stages of B-cell development. Immunol. Rev. 175, 138–149 (2000).
Bain, G., Quong, M. W., Soloff, R. S., Hedrick, S. M. & Murre, C. Thymocyte maturation is regulated by the activity of the helix-loop-helix protein, E47. J. Exp. Med. 190, 1605–1616 (1999).
Engel, I. & Murre, C. Ectopic expression of E47 or E12 promotes the death of E2A-deficient lymphomas. Proc. Natl Acad. Sci. USA 96, 996–1001 (1999).
Bain, G. et al. Both E12 and E47 allow commitment to the B cell lineage. Immunity 6, 145–154 (1997).
Acknowledgements
We thank M. Becker-Hapak for suggestions on purification of TAT-fusion proteins; M. Quong for sharing preliminary data; V. Laurent for technical assistance; L. Penn and M. Montminy for suggestions and comments on the manuscript. Supported by a Special Fellowship from the Leukemia and Lymphoma Society of America (to B. L. K.) and grants from the National Institutes of Health (NIH) and the Edward Mallinckrodt Jr. Foundation (to C. M).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kee, B., Rivera, R. & Murre, C. Id3 inhibits B lymphocyte progenitor growth and survival in response to TGF-β. Nat Immunol 2, 242–247 (2001). https://doi.org/10.1038/85303
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/85303
This article is cited by
-
Immune Inhibitory Properties and Therapeutic Prospects of Transforming Growth Factor-Beta and Interleukin 10 in Autoimmune Hepatitis
Digestive Diseases and Sciences (2022)
-
SARS-CoV-2 in severe COVID-19 induces a TGF-β-dominated chronic immune response that does not target itself
Nature Communications (2021)
-
Depletion of ID3 enhances mesenchymal stem cells therapy by targeting BMP4 in Sjögren’s syndrome
Cell Death & Disease (2020)
-
Single-cell RNA-sequencing identifies the developmental trajectory of C-Myc-dependent NK1.1− T-bet+ intraepithelial lymphocyte precursors
Mucosal Immunology (2020)
-
BMP3 suppresses colon tumorigenesis via ActRIIB/SMAD2-dependent and TAK1/JNK signaling pathways
Journal of Experimental & Clinical Cancer Research (2019)